PANTHERx® at Specialty Therapies Conference

Join one of the leaders from PANTHERx® Specialty Pharmacy at the 15th annual Specialty Therapies Conference, January 25-26, in Las Vegas, Nevada.  The conference brings together payers, specialty pharmacies, and pharmaceutical representatives to discuss the challenges of paying for innovative therapies for the treatment of diseases.  Discussions focus on current issues in specialty therapy management, cost containment, patient satisfaction and adherence.

PANTHERx® Vice President of Quality & Education, Doug Gebhard, will be speaking during a workshop on Thursday, January 25th at 8:30am titled “Considerations for Accreditation and Expanding Reach for Specialty Pharmacies” as part of a cross-functional discussion regarding considerations for gaining access to Specialty Therapies.  Doug will also be presenting later in the day at 4:15pm on “Orphan Drugs – The Reinvention of Specialty Pharmacy?” focusing on the current landscape of the Orphan Drug market and the role Specialty Pharmacies can play in managing complex patient therapies.

Connect with Doug outside of the scheduled agenda sessions by emailing him at

PANTHERx® at J.P. Morgan Healthcare Conference

PANTHERx® Chairman and CEO, Dr. Gordon J. Vanscoy, has been invited to join world business leaders at the 36th annual J.P. Morgan Healthcare Conference, January 8-11, at the Westin St. Francis in San Francisco.  Focused on companies that are shaping today and tomorrow’s healthcare industry, the conference brings together healthcare executives, representatives from dynamic, fast-growing organizations, technology innovators, and investors.

As THE Rare Disease Specialty Pharmacy®, PANTHERx’s mission is to Reinvent Specialty, Revolutionize Pharmacy, and Redefined Care®, by developing solutions, bold innovations, and novel clinical services for emerging orphan and rare disease therapies. Gordon’s attendance represents the continued focus of PANTHERx® to serve patients and partners in the delicate journey to manage rare and devastating conditions as critical cures and lifesaving pharmaceuticals emerge.

Connect with Dr. Vanscoy by emailing his Executive Administrator, Lisa Nacey at to prepare an introduction or appointment.